Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Galaxy Launches Institutional OTC Prediction Markets Trading
-
DataCapable Appoints Bob Flaherty as Chief Operating Officer
-
Angeles Equity Partners Adds Chris Huetsch to Investment Team
-
Force Management Announces New CRO
-
TASKING Wins VDC’s Embeddy Award for Industry’s First Integrated Compile, Debug and Test Toolchain for Renesas RH850 Microcontrollers
-
Argyle expands consent-based verification platform for state government agencies with new benefits-focused capabilities
-
Cardinal Infrastructure Group Announces Acquisition of Piedmont Pipe Construction
-
Agility Retail Group Acquires The Marco Company
-
CI Global Asset Management Announces Name Changes for 37 Former Invesco Mutual Funds and ETFs
-
Voyager to Acquire Astrobotic Technology, Accelerating America’s Path to the Moon
-
Luxe Haus Launches The Luxe Haus Golf Experience Park City & Deer Valley
-
ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine
-
ConnectSecure Partners with TD SYNNEX to Expand Access to Affordable, Flexible Cybersecurity Worldwide
-
SICK Integrates Aeva’s High-Precision Technology into Industrial Sensing Product Line
-
StandardAero Announces CEO Succession Plan
-
Neuropacs Announces the Publication of a New Study Comparing the First‑of‑Its‑Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease with CSF Alpha‑Synuclein Seed Amplificat
-
NationsBenefits Appoints Irina Pelphrey to Scale Food is Medicine Strategy and Healthcare Infrastructure
-
Maxwell TEC's nanaCONNECT Platform Surpasses One Million Patient and Family Text Messages
-
Moody’s to Host Q&A Session on Generative AI Strategy on June 8, 2026
-
Weaver Launches as the AI-Native Systems Integrator That Proves the ROI Before It Builds
-
Can-Fite Reports Positive Clinical Observation in Phase 2a Pancreatic Cancer Study and Highlights Namodenoson’s RAS Signaling Inhibition Mechanism
-
The H&H Group Continues Growth Momentum with ReposiTrak SBT 2.0
-
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
-
ODDITY Tech Reports First Quarter 2026 Results, Makes Progress Toward Normalization
-
Soleo Health Acquires Realo Specialty Care Pharmacy and BluHaven Management, Expanding Footprint in Mid-Atlantic Region
-
Kodiak AI Named to Inc.’s 2026 Best Workplaces List
-
Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York
-
Troilus Receives Full Power Allocation from Hydro-Québec and Quebec’s Ministère de l'Économie, de l'Innovation et de l'Énergie (MEIE) to Support Mine Construction and Operations
-
X-energy Submits Xe-100 HTGR for UK Generic Design Assessment
-
SOLV Energy Scales Up, Now Supporting Multiple 600+ MW Solar and Battery Projects Totaling More than 4 GW Across the U.S.
-
Mission Critical Group Opens Third Pennsylvania Manufacturing Facility to Support Growing AI and Data Center Infrastructure Demand
-
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
-
Livium and Garage Composites Form Strategic Partnership to Deliver Unmatched Performance Solutions for Powersports Dealers
-
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
-
AlphaSense Named to Inc.’s 2026 Best Workplaces List
-
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
-
AskNicely Launches AI Agents to Automate Customer Insights and Reputation Management
-
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096
-
Uraniumx Reports Visually Identified Pitchblende At Murphy Lake
-
Augustine Therapeutics to Present Late-Breaking Poster at the American Diabetes Association’s 86th Scientific Sessions
-
Tintina Mines Announces C$91 Million Private Placement and Strategic Partnership with the Gignac Family and Sumitomo Corporation for the Development of the Domeyko Sulfuros Copper-Gold Project in Chil
-
Notice of annual general meeting
-
New Found Gold Expands Queensway Work Program: Focus on Discovery and Resource Growth
-
Accenture to Announce Third-Quarter Fiscal 2026 Results
-
Fury Reports 7.86 g/t Gold Over 9.43 Metres in Infill Drilling at the Eau Claire Gold Project, Quebec
-
Form 8.3 Bluefield Solar Income Fund Ltd.
-
Anuvia Pioneers a First-of-Its-Kind Virtual Nursing Model for Behavioral Health and Addiction Treatment with VirtuAlly and AvaSure
-
Best Crypto Presale Alert: APEMARS Joins Ethereum, XRP, and Solana Among the Top 10 Altcoins to Watch as It Raises Over $500K
-
Bowman Secures Significant Mining-Related Awards
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
